Parallax Volatility Advisers, L.P. Acadia Pharmaceuticals Inc Put Options Transaction History

Parallax Volatility Advisers, L.P.

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $831,200 - $1.27 Million	40,000 New	40,000 $1.25 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $53,400 - $76,950	3,000 Added 11.11%	30,000 $718,000
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $440,640 - $564,840	27,000 New	27,000 $508,000
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $2.46 Million - $3.41 Million	-60,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$36.42 - $57.0 $520,806 - $815,100	14,300 Added 31.29%	60,000 $2.48 Million
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $412,918 - $612,116	-27,400 Reduced 37.48%	45,700 $698,000
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $69,657 - $100,223	3,100 Added 4.43%	73,100 $1.64 Million
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $2.06 Million - $2.69 Million	70,000	70,000 $2.64 Million

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.